HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Bokf Na

Bokf Na raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,541 shares of the company’s stock after acquiring an additional 144 shares during the period. Bokf Na’s holdings in HCA Healthcare were worth $1,499,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Lazard Asset Management LLC boosted its stake in HCA Healthcare by 44.3% in the first quarter. Lazard Asset Management LLC now owns 214,669 shares of the company’s stock valued at $71,597,000 after acquiring an additional 65,926 shares during the period. Epoch Investment Partners Inc. raised its holdings in shares of HCA Healthcare by 18.7% during the first quarter. Epoch Investment Partners Inc. now owns 542,906 shares of the company’s stock valued at $181,075,000 after buying an additional 85,505 shares during the last quarter. LRI Investments LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $69,000. 1832 Asset Management L.P. bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $26,672,000. Finally, Quadrature Capital Ltd raised its holdings in shares of HCA Healthcare by 136.7% during the first quarter. Quadrature Capital Ltd now owns 62,098 shares of the company’s stock valued at $20,703,000 after buying an additional 35,866 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HCA shares. Robert W. Baird started coverage on HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price target on the stock. Barclays boosted their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday. SVB Leerink boosted their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Finally, Oppenheimer boosted their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $339.72.

HCA Healthcare Trading Up 0.6 %

NYSE HCA traded up $1.99 on Friday, hitting $354.78. 1,215,941 shares of the stock were exchanged, compared to its average volume of 1,679,664. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $356.30. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 1.02. The company has a market capitalization of $92.92 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.35 and a beta of 1.68. The company’s 50-day moving average price is $330.12 and its two-hundred day moving average price is $323.11.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the previous year, the company posted $4.29 EPS. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. Research analysts predict that HCA Healthcare, Inc. will post 22.43 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Activity

In other news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at approximately $6,397,042.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now directly owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock worth $3,921,929 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.